Skip to main content

Table 2 Fleas recovered in premises flea traps in naturally infested homes when dogs were administered either Sarolaner or Spinosad oral treatments

From: Evaluation of sarolaner and spinosad oral treatments to eliminate fleas, reduce dermatologic lesions and minimize pruritus in naturally infested dogs in west Central Florida, USA

Treatment group

No. of homes on day 0

 

Days post-treatmenta

Day 0

Day 7

Day 14

Day 21

Day 28–30

Day 40–45

Day 56–60

Sarolanerb

19

Geomeand

29.39

4.08

4.14

1.25

1.14

0.26

0.00

% controle

 

86.11

85.92

95.74

96.12

99.13

100

Range

6–1163

0–164

0–61

0–58

0–39

0–2

0–0

Spinosadc

16

Geomean

20.99

4.65

2.38

1.27

1.07

0.04

0.04

% control

 

77.83

88.65

93.95

94.91

99.80

99.79

Range

6–138

0–49

0–16

0–16

0–4

0–1

0–1

  1. aIn both groups, dogs were treated on day 0 and once between days 28–30
  2. bDogs were orally administered Sarolaner chewables (Simparica® Zoetis) according to label directions
  3. cDogs were orally administered Spinosad flavored tablets (Comfortis® Elanco) according to label directions
  4. dGeometric mean numbers of fleas recovered in two intermittent light flea traps averaged within households
  5. e{(Day 0 geometric mean trap flea counts – day x geometric mean trap flea counts) / day 0 geometric mean trap flea counts)} × 100
Back to article page

Parasites & Vectors

ISSN: 1756-3305

Contact us